Stoke Therapeutics, Inc. (STOK): Weighted Average Diluted Shares
59.22M
Year ended 2025-12-31
+15.0%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 59.22M | +9.6% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | 54.01M | +22.8% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | 43.99M | +13.1% | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | 38.90M | +5.9% | 2024-03-25, From 2022-01-01 |
| 2021-12-31 | 36.74M | n/a | 2023-03-06, From 2021-01-01 |